Jeffrey Dorr, MD - Medicare Diagnostic Radiology in East Brunswick, NJ

Jeffrey Dorr, MD is a medicare enrolled "Radiology - Diagnostic Radiology" physician in East Brunswick, New Jersey. He went to University Of Florida College Of Medicine and graduated in 2012 and has 12 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice University Radiology Group Llc, Flemington Radiology Associates Llc, University Radiology Group Llc, University Radiology Group Llc, Flemington Radiology Associates Llc, University Radiology Group Llc and his current practice location is 483 Cranbury Rd, East Brunswick, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 390-0030.

Jeffrey Dorr is licensed to practice in New Jersey (license number 25MA10332100) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013279595.

Contact Information

Jeffrey Dorr, MD
483 Cranbury Rd,
East Brunswick, NJ 08816-3610
(732) 390-0030
(732) 390-5383



Physician's Profile

Full NameJeffrey Dorr
GenderMale
SpecialityDiagnostic Radiology
Experience12 Years
Location483 Cranbury Rd, East Brunswick, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Jeffrey Dorr attended and graduated from University Of Florida College Of Medicine in 2012
  NPI Data:
  • NPI Number: 1013279595
  • Provider Enumeration Date: 06/12/2012
  • Last Update Date: 09/11/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 9436436755
  • Enrollment ID: I20170515000664

Medical Identifiers

Medical identifiers for Jeffrey Dorr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013279595NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology 25MA10332100 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Robert Wood Johnson University HospitalNew brunswick, NJHospital
Monmouth Medical CenterLong branch, NJHospital
Hunterdon Medical CenterFlemington, NJHospital
Jersey City Medical CenterJersey city, NJHospital
Saint Peter's University HospitalNew brunswick, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Radiology Group Llc6608868500213
Flemington Radiology Associates Llc529414581955
University Radiology Group Llc6608868500213
University Radiology Group Llc6608868500213
Flemington Radiology Associates Llc529414581955
University Radiology Group Llc6608868500213

News Archive

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.

Study: Breast cancer screening rates declined in low-income communities during the pandemic

A new study finds breast cancer screening rates (BCSR) declined among women aged 50 to 74 years within 32 community health centers that serve lower-income populations during the COVID-19 pandemic in the United States.

Viewpoints: The evolution of Medicare; generic drugs and patient safety; new food labels

About half a century ago, organized medicine and the hospital industry in this country struck a deal with Congress that in retrospect seems as audacious as it seems incredible: Congress was asked to surrender to these industries the keys to the United States Treasury. In return, the industries would allow Congress to pass a 1965 amendment to the Social Security Act .... We have come to know it as Medicare.

Tool to help vulnerable people to manage their medicines

Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jeffrey Dorr allows following entities to bill medicare on his behalf.
Entity NameHarbor Medical Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1124079561
PECOS PAC ID: 2466356209
Enrollment ID: O20040719000954

News Archive

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.

Study: Breast cancer screening rates declined in low-income communities during the pandemic

A new study finds breast cancer screening rates (BCSR) declined among women aged 50 to 74 years within 32 community health centers that serve lower-income populations during the COVID-19 pandemic in the United States.

Viewpoints: The evolution of Medicare; generic drugs and patient safety; new food labels

About half a century ago, organized medicine and the hospital industry in this country struck a deal with Congress that in retrospect seems as audacious as it seems incredible: Congress was asked to surrender to these industries the keys to the United States Treasury. In return, the industries would allow Congress to pass a 1965 amendment to the Social Security Act .... We have come to know it as Medicare.

Tool to help vulnerable people to manage their medicines

Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

Read more Medical News

› Verified 9 days ago

Entity NamePhysicians Of Cape Cod Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1679832364
PECOS PAC ID: 9638326671
Enrollment ID: O20120828000193

News Archive

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.

Study: Breast cancer screening rates declined in low-income communities during the pandemic

A new study finds breast cancer screening rates (BCSR) declined among women aged 50 to 74 years within 32 community health centers that serve lower-income populations during the COVID-19 pandemic in the United States.

Viewpoints: The evolution of Medicare; generic drugs and patient safety; new food labels

About half a century ago, organized medicine and the hospital industry in this country struck a deal with Congress that in retrospect seems as audacious as it seems incredible: Congress was asked to surrender to these industries the keys to the United States Treasury. In return, the industries would allow Congress to pass a 1965 amendment to the Social Security Act .... We have come to know it as Medicare.

Tool to help vulnerable people to manage their medicines

Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

Read more Medical News

› Verified 9 days ago

Entity NameBrigham And Women's Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033535497
PECOS PAC ID: 3870405988
Enrollment ID: O20150107001260

News Archive

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.

Study: Breast cancer screening rates declined in low-income communities during the pandemic

A new study finds breast cancer screening rates (BCSR) declined among women aged 50 to 74 years within 32 community health centers that serve lower-income populations during the COVID-19 pandemic in the United States.

Viewpoints: The evolution of Medicare; generic drugs and patient safety; new food labels

About half a century ago, organized medicine and the hospital industry in this country struck a deal with Congress that in retrospect seems as audacious as it seems incredible: Congress was asked to surrender to these industries the keys to the United States Treasury. In return, the industries would allow Congress to pass a 1965 amendment to the Social Security Act .... We have come to know it as Medicare.

Tool to help vulnerable people to manage their medicines

Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

Read more Medical News

› Verified 9 days ago

Entity NameUniversity Radiology Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154367803
PECOS PAC ID: 6608868500
Enrollment ID: O20180809001172

News Archive

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.

Study: Breast cancer screening rates declined in low-income communities during the pandemic

A new study finds breast cancer screening rates (BCSR) declined among women aged 50 to 74 years within 32 community health centers that serve lower-income populations during the COVID-19 pandemic in the United States.

Viewpoints: The evolution of Medicare; generic drugs and patient safety; new food labels

About half a century ago, organized medicine and the hospital industry in this country struck a deal with Congress that in retrospect seems as audacious as it seems incredible: Congress was asked to surrender to these industries the keys to the United States Treasury. In return, the industries would allow Congress to pass a 1965 amendment to the Social Security Act .... We have come to know it as Medicare.

Tool to help vulnerable people to manage their medicines

Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jeffrey Dorr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jeffrey Dorr, MD
579a Cranbury Rd,
East Brunswick, NJ 08816-5426

Ph: (732) 390-0040
Jeffrey Dorr, MD
483 Cranbury Rd,
East Brunswick, NJ 08816-3610

Ph: (732) 390-0030

News Archive

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx Biopharmaceuticals, Inc. announced that it has received a notice from the U.S. Food and Drug Administration (FDA) indicating that, due to non-compliance with FDA's current Good Manufacturing Practice (cGMP) regulations by its contract manufacturer, the Company's Phase 2 clinical trial of RGN-352, its injectable formulation of Thymosin beta 4 for the treatment of acute myocardial infarction (AMI), has been placed on clinical hold.

Study: Breast cancer screening rates declined in low-income communities during the pandemic

A new study finds breast cancer screening rates (BCSR) declined among women aged 50 to 74 years within 32 community health centers that serve lower-income populations during the COVID-19 pandemic in the United States.

Viewpoints: The evolution of Medicare; generic drugs and patient safety; new food labels

About half a century ago, organized medicine and the hospital industry in this country struck a deal with Congress that in retrospect seems as audacious as it seems incredible: Congress was asked to surrender to these industries the keys to the United States Treasury. In return, the industries would allow Congress to pass a 1965 amendment to the Social Security Act .... We have come to know it as Medicare.

Tool to help vulnerable people to manage their medicines

Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

Read more News

› Verified 9 days ago


Radiology Doctors in East Brunswick, NJ

Salim Samuel, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 579a Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816
Phone: 732-390-0040    Fax: 732-390-1856
David L Rosenfeld, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 483 Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816
Phone: 732-390-0030    Fax: 732-390-5383
Dr. Levi Olatokunbo Sokol, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 483 Cranbury Rd, East Brunswick, NJ 08816
Phone: 732-390-0040    Fax: 732-390-1856
Stephen William Warren, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 579a Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816
Phone: 732-390-0040    Fax: 732-390-1856
Douglas Mark Solonick, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 579a Cranbury Rd, University Radiology Group Pc, East Brunswick, NJ 08816
Phone: 732-390-0040    Fax: 732-390-1856
Harsha Jonna, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 579a Cranbury Rd, East Brunswick, NJ 08816
Phone: 732-390-0040    Fax: 732-390-1856

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.